Clinical Trial Update: Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet

View source ↗

Summary

A completed clinical trial evaluated switching type 2 diabetes patients from a sulfonylurea with metformin to a glyburide/metformin combination tablet. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glyburide/Metformin (glyburide and metformin)

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED